Evidence map›Paper›PMID 35890218›Full record

ArticlePharmaceutics2022

RETRACTED: Therapeutic Potential of Mesenchymal Stem Cells versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration.

Fatma Y Meligy, Hanan Sharaf El-Deen Mohammed, Tarek M Mostafa, Mohamed M Elfiky, Israa El-Sayed Mohamed Ashry, Ahmed M Abd-Eldayem, Nermin I Rizk, Dina Sabry, Eman S H Abd Allah, Salwa Fares Ahmed

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Fatma Y MeligyHistology and Cell Biology Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.ORCID 0000-0002-6372-8731
Hanan Sharaf El-Deen MohammedInternal Medicine_Critical Care Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.
Tarek M MostafaAnatomy and Embryology Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.
Mohamed M ElfikyAnatomy and Embryology Department, Faculty of Medicine, Menoufia University, Menoufia 32952, Egypt.ORCID 0000-0001-9677-7970
Israa El-Sayed Mohamed AshryPharmacology Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.ORCID 0000-0003-3497-3006
Ahmed M Abd-EldayemPharmacology Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.ORCID 0000-0002-3093-8572
Nermin I RizkClinical Physiology Department, Faculty of Medicine, Menoufia University, Menoufia 32952, Egypt.
Dina SabryMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Badr University in Cairo, Cairo 11829, Egypt.ORCID 0000-0002-6720-3385
Eman S H Abd AllahMedical Physiology Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.
Salwa Fares AhmedHistology and Cell Biology Department, Faculty of Medicine, Assiut University, Assiut 71526, Egypt.ORCID 0000-0002-4330-9900
Assiut University · EGMenoufia University · EGCairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study compared the cardioprotective action of mesenchymal stem cells (MSCs) and PUFAs in a rat model of gentamicin (GM)-induced cardiac degeneration. Male Wistar albino rats were randomized into four groups of eight rats each: group I (control group), group II (gentamicin-treated rats receiving gentamicin intraperitoneally (IP) at dose of 100 mg/kg/day for 10 consecutive days), group III (gentamicin and PUFA group receiving gentamicin IP at dose of 100 mg/kg/day for 10 consecutive days followed by PUFAs at a dose of 100 mg/kg/day for 4 weeks), and group IV (gentamicin and MSC group receiving gentamicin IP at dose of 100 mg/kg/day followed by a single dose of MSCs (1 × 10

Indexed as

cardiac degenerationcaspase-3catalaseMDAmesenchymal stem cellsn − 3 polyunsaturated fatty acidsPCNA

Identifiers

PMID35890218
PMCPMC9319609
OpenAlexW4283323106

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.